ROIV - Roivant Sciences Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$46.75
DETAILS
HIGH:
$55.00
LOW:
$40.00
MEDIAN:
$46.50
CONSENSUS:
$46.75
UPSIDE:
38.68%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Halvorsen | 6,271,467 | $221.9M | 0.6% | -380,981 | DECREASED |
| Cooperman | 2,972,702 | $105.2M | 0.1% | +1,579,954 | INCREASED |
| Greenblatt | 1,349,465 | $47.8M | 0.1% | -66,626 | DECREASED |
| Wood | 6,600 | $233,574 | 0.0% | -40,800 | DECREASED |
| Soros | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-10-01 | Epperly Melissa B, | director | SELL | 900 | $36.57 | $33K |
| 2026-10-01 | Epperly Melissa B, | director | SELL | 16,850 | $36.08 | $608K |
| 2026-10-01 | Epperly Melissa B, | director | M-Exempt | 17,750 | $4.46 | $79K |
| 2026-09-30 | Gline Matthew | director, officer: CEO | F-InKind | 76,171 | $36.57 | $2.8M |
| 2026-09-30 | Torti Frank | officer: President and Vant Chair | F-InKind | 40,309 | $36.57 | $1.5M |
| 2026-09-30 | Sukhatme Mayukh | director, officer: President & CIO | F-InKind | 46,879 | $36.57 | $1.7M |
| 2026-09-30 | Venker Eric | officer: President & Immunovant CEO | SELL | 200,000 | $36.62 | $7.3M |
| 2026-09-30 | Venker Eric | officer: President & Immunovant CEO | M-Exempt | 200,000 | $3.85 | $770K |
| 2026-09-20 | Humes Jennifer | officer: Chief Accounting Officer | F-InKind | 3,880 | $39.77 | $154K |
| 2026-09-20 | Pulik Richard | officer: CFO | F-InKind | 2,129 | $39.77 | $85K |
| 2026-09-16 | Gold Daniel Allen | director | A-Award | 10,531 | $39.57 | $417K |
| 2026-09-16 | Oren Ilan | director | A-Award | 5,054 | -- | -- |
| 2026-09-16 | Epperly Melissa B, | director | A-Award | 5,054 | -- | -- |
| 2026-09-16 | Oren Ilan | director | A-Award | 10,531 | $39.57 | $417K |
| 2026-09-16 | Epperly Melissa B, | director | A-Award | 10,531 | $39.57 | $417K |
| 2026-09-16 | Fitzgerald Meghan | director | A-Award | 5,054 | -- | -- |
| 2026-09-16 | Fitzgerald Meghan | director | A-Award | 10,531 | $39.57 | $417K |
| 2026-09-16 | MOMTAZEE JAMES C | director | A-Award | 5,054 | -- | -- |
| 2026-09-16 | MOMTAZEE JAMES C | director | A-Award | 10,531 | $39.57 | $417K |
| 2026-09-16 | MANCHESTER KEITH S | director | A-Award | 5,054 | -- | -- |
| 2026-09-16 | MANCHESTER KEITH S | director | A-Award | 10,531 | $39.57 | $417K |
| 2026-09-16 | Gold Daniel Allen | director | A-Award | 5,054 | -- | -- |
| 2026-09-15 | Epperly Melissa B, | director | SELL | 4,338 | $39.65 | $172K |
| 2026-09-15 | Epperly Melissa B, | director | SELL | 600 | $40.38 | $24K |
| 2026-09-15 | Fitzgerald Meghan | director | SELL | 4,712 | $39.68 | $187K |